Summary of findings 1. Action observation versus control: effect on upper limb rehabilitation after stroke.
Action observation versus control: effect on upper limb rehabilitation after stroke | ||||||
Patient or population: upper limb rehabilitation after stroke Setting: hospital, clinic, research laboratory or home Intervention: action observation Comparison: control | ||||||
Outcomes | Anticipated absolute effects* (95% CI) | Relative effect (95% CI) | № of participants (trials) | Certainty of the evidence (GRADE) | Comments | |
Risk with control | Risk with action observation | |||||
Arm function assessed by: Action Research Arm Test, Fugl‐Meyer Assessment, Wolf Motor Function Test Follow‐up: range 16 to 24 weeks |
The mean arm function was 0 SD | SMD 0.39 higher (0.17 higher to 0.61 higher) | ‐ | 373 (11 RCTs) | ⊕⊕⊝⊝ Lowa,b | Action observation may result in a slight increase in arm function. |
Hand function assessed by: Box and Block Test Follow‐up: range 12 to 20 weeks | The mean hand function was 0 | MD 2.76 higher (1.04 higher to 4.49 higher) | ‐ | 178 (5 RCTs) | ⊕⊕⊝⊝ Low a,b | Action observation may result in a slight increase in hand function. |
Dependence on ADL assessed by: Barthel Index, Functional Independence Measure Follow‐up: range 12 to 20 weeks | The mean dependence on activities of daily living was 0 | SMD 0.37 higher (0.34 lower to 1.08 higher) | ‐ | 302 (7 RCTs) | ⊕⊝⊝⊝ Very lowa,b,c | Action observation may increase/have little to no effect on dependence on activities of daily living but the evidence is very uncertain. |
Quality of life assessed by: Stroke Impact Scale Follow‐up: range 8 to 12 weeks | The mean quality of life was 0 | SMD 0.13 higher (1.76 lower to 2.02 higher) | ‐ | 30 (2 RCTs) | ⊕⊝⊝⊝ Very lowa,b,c | The evidence is very uncertain about the effect of action observation on quality of life. |
Cortical activation assessed by: fMRI, MEP, EEG |
See comment | See comment | ‐ | 102 (4 RCTs) |
‐ | Trials could not be pooled due to the variety of measures and the absence of data in some groups. |
Motor performance assessed by: Accelerometer, 3‐dimensional motion analysis system, number of acting Follow‐up: mean 1 week | See comment | See comment | ‐ | 91 (4 RCTs) | ‐ | Trials could not be pooled due to the variety of measures. Experimental groups showed improvements in movement time, peak acceleration and number of repetitions of a task in 1 minute. |
Adverse effects | See comment | See comment | ‐ | 16 (2 RCTs) | ‐ | Trials could not be pooled due to subjectivity of the outcome assessment |
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). ADL: activities of daily living; CI: confidence interval; EEG: electroencephalography; fMRI: functional magnetic resonance imaging; MD: mean difference; MEP: motor evoked potential;RCTs: randomized controlled trials; SD: standard deviation; SMD: standardized mean difference. | ||||||
GRADE Working Group grades of evidence High certainty: we are very confident that the true effect lies close to that of the estimate of the effect. Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. |
aDowngraded one level due to several ratings with 'unclear' or even 'high' risk of bias in allocation concealment, incomplete outcome data, blinding of outcome assessment or selective reporting. bDowngraded one level due to small total population size (< 400). cDowngraded one level due to moderate or high heterogeneity (> 50%).